Quent Capital, LLC Veracyte, Inc. Transaction History
Quent Capital, LLC
- $912 Million
- Q1 2025
A detailed history of Quent Capital, LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Quent Capital, LLC holds 11,354 shares of VCYT stock, worth $353,563. This represents 0.04% of its overall portfolio holdings.
Number of Shares
11,354
Previous 22,472
49.47%
Holding current value
$353,563
Previous $889,000
61.64%
% of portfolio
0.04%
Previous 0.1%
Shares
4 transactions
Others Institutions Holding VCYT
# of Institutions
339Shares Held
76.8MCall Options Held
212KPut Options Held
18.5K-
Vanguard Group Inc Valley Forge, PA8.21MShares$256 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.79MShares$243 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI6.6MShares$206 Million0.42% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.2MShares$131 Million1.46% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO3.08MShares$95.9 Million1.83% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $2.23B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...